Specific granule deficiency

Specific Granule Deficiency (SGD) is a rare hematologic disorder characterized by a decrease or absence of specific granules in neutrophils, which are a type of white blood cell crucial for fighting off infections. This condition is part of a group of disorders known as primary immunodeficiency diseases, which affect the body's ability to defend itself against pathogens.

Etiology

The cause of Specific Granule Deficiency is genetic. It is often associated with mutations in the CEBPE gene, which plays a critical role in the development and maturation of neutrophils, specifically in the formation of secondary or specific granules. These granules contain important antimicrobial proteins and enzymes necessary for the neutrophils' function in the immune response.

Pathophysiology

In SGD, the absence or severe reduction of specific granules impairs the neutrophils' ability to effectively combat infections. Neutrophils are still produced and can migrate to sites of infection, but their bactericidal activity is significantly compromised. This leads to an increased susceptibility to bacterial and fungal infections from an early age.

Clinical Manifestations

Individuals with Specific Granule Deficiency typically present with recurrent bacterial and fungal infections from infancy. These infections can be severe and include conditions such as pneumonia, skin infections, and sepsis. Due to the compromised immune response, these infections may be more difficult to treat and may recur despite appropriate therapy.

Diagnosis

Diagnosis of SGD is based on clinical presentation and laboratory findings. A complete blood count (CBC) may show normal or increased numbers of neutrophils. However, a definitive diagnosis requires examination of the neutrophils under a microscope after staining, which reveals the absence or marked decrease of specific granules. Genetic testing can confirm mutations in the CEBPE gene.

Treatment

There is no cure for Specific Granule Deficiency. Treatment focuses on managing infections through the use of antibiotics and antifungal medications. In some cases, prophylactic (preventive) antibiotics may be used to reduce the frequency of infections. Bone marrow transplantation has been explored as a potential curative treatment for SGD, but it is considered on a case-by-case basis due to the risks associated with the procedure.

Prognosis

The prognosis for individuals with Specific Granule Deficiency varies. With aggressive management of infections, many individuals can lead relatively normal lives. However, the risk of severe, life-threatening infections remains a significant concern.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian